West Pharmaceutical Services, Inc. (WST) Earnings History
Steady Earner37 years of earnings data (1989–2025) · Positive but moderate multi-year EPS trajectory
Loading earnings history...
West Pharmaceutical Services, Inc. (WST) Earnings Overview
As of October 18, 2026, West Pharmaceutical Services, Inc. (WST) reported trailing twelve-month net income of $565M, reflecting +1.6% year-over-year growth. The company earned $7.92 per diluted share over the past four quarters, with a net profit margin of 16.1%.
Looking at the long-term picture, WST's 5-year EPS compound annual growth rate (CAGR) stands at +8.3%, showing solid earnings momentum. The company achieved its highest annual net income of $662M in fiscal 2021.
West Pharmaceutical Services, Inc. maintains industry-leading profitability with a gross margin of 35.9%, operating margin of 20.1%, and net margin of 16.1%. This margin structure demonstrates strong pricing power and operational efficiency. View revenue history →
Compared to peers including ATR ($363M net income, 10.4% margin), GTLS (-$26M net income, 1.0% margin), AVTR (-$578M net income, -8.1% margin), WST has outperformed on profitability metrics. Compare WST vs ATR →
WST Earnings vs Peers
Earnings metrics vs comparable public companies
WST Historical Earnings Data (1989–2025)
37 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $494M | +0.2% | $617M | $6.80 | 16.1% | 20.1% |
| 2024 | $493M | -17.0% | $595M | $6.69 | 17.0% | 20.6% |
| 2023 | $593M | +1.3% | $711M | $7.88 | 20.1% | 24.1% |
| 2022 | $586M | -11.5% | $764M | $7.73 | 20.3% | 26.5% |
| 2021 | $662M | +91.2% | $759M | $8.67 | 23.4% | 26.8% |
| 2020 | $346M | +43.2% | $419M | $4.57 | 16.1% | 19.5% |
| 2019 | $242M | +16.8% | $297M | $3.21 | 13.1% | 16.1% |
| 2018 | $207M | +37.3% | $255M | $2.74 | 12.0% | 14.8% |
| 2017 | $151M | +4.9% | $230M | $1.99 | 9.4% | 14.4% |
| 2016 | $144M | +50.2% | $216M | $1.91 | 9.5% | 14.3% |
| 2015 | $96M | -24.8% | $126M | $1.30 | 6.8% | 9.0% |
| 2014 | $127M | +13.2% | $182M | $1.75 | 8.9% | 12.8% |
| 2013 | $112M | +39.2% | $157M | $1.57 | 8.2% | 11.5% |
| 2012 | $81M | +6.9% | $137M | $1.15 | 6.4% | 10.8% |
| 2011 | $76M | +15.6% | $116M | $1.08 | 6.3% | 9.7% |
| 2010 | $65M | -10.1% | $106M | $0.95 | 5.9% | 9.6% |
| 2009 | $73M | -15.6% | $106M | $1.06 | 6.9% | 10.0% |
| 2008 | $86M | +21.6% | $125M | $1.25 | 8.2% | 11.9% |
| 2007 | $71M | +5.4% | $113M | $1.02 | 6.9% | 11.1% |
| 2006 | $67M | +47.1% | $106M | $1.00 | 7.3% | 11.6% |
| 2005 | $46M | +135.1% | $73M | $0.71 | 6.5% | 10.5% |
| 2004 | $19M | -39.2% | $64M | $0.56 | 3.6% | 11.8% |
| 2003 | $32M | +73.4% | $55M | $0.75 | 6.5% | 11.1% |
| 2002 | $18M | +453.8% | $27M | $0.33 | 4.4% | 6.4% |
| 2001 | -$5M | -425.0% | $41M | $-0.09 | -1.3% | 10.4% |
| 2000 | $2M | -95.9% | $36M | $0.03 | 0.4% | 8.3% |
| 1999 | $39M | +477.6% | $66M | $0.64 | 8.2% | 14.2% |
| 1998 | $7M | -84.9% | $65M | $0.10 | 1.5% | 14.4% |
| 1997 | $44M | +170.7% | $62M | $0.67 | 9.8% | 13.7% |
| 1996 | $16M | -42.9% | $53M | $0.25 | 3.6% | 11.6% |
| 1995 | $29M | +5.1% | $48M | $0.43 | 7.0% | 11.7% |
| 1994 | $27M | +16.2% | $47M | $0.43 | 7.5% | 12.9% |
| 1993 | $24M | +19.3% | $41M | $0.37 | 6.7% | 11.8% |
| 1992 | $20M | +331.8% | $40M | $0.31 | 5.8% | 11.7% |
| 1991 | -$9M | -297.7% | -$1M | $-0.14 | -2.6% | -0.4% |
| 1990 | $4M | -79.2% | $21M | $0.07 | 1.3% | 6.6% |
| 1989 | $21M | - | $36M | $0.32 | 6.7% | 11.7% |
Download Data
Export WST earnings history in CSV or JSON format
Free sign-in required to download data
WST Chart Terminal
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
Live Breakouts Feed
High-probability breakout stocks crossing their pivot across 5 pattern engines.
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
37+ years return with dividends reinvested.
Peer Comparison
Compare growth, multiples, and margins vs sector.
WST — Frequently Asked Questions
Quick answers to the most common questions about buying WST stock.
What is WST earnings per share (EPS)?
WST trailing twelve-month (TTM) diluted EPS is $7.92, reflecting +1.6% year-over-year growth. The 5-year EPS CAGR is +8.3%. Complete EPS history from 1989 to 2025 is available in the table on this page.
What is West Pharmaceutical Services, Inc.'s net income?
West Pharmaceutical Services, Inc. (WST) trailing twelve-month net income is $565M as of 2025. Earnings grew +1.6% year-over-year. West Pharmaceutical Services, Inc. has been profitable for 24 consecutive years.
Is WST profitable?
Yes, WST is profitable with a TTM net income of $565M and a net profit margin of +16.1%. West Pharmaceutical Services, Inc. has generated profits for 24 consecutive years.
What is WST's earnings growth rate?
WST compound annual EPS growth rates (CAGR): 1-Year: +1.6%, 3-Year: -4.2%, 5-Year: +8.3%, 10-Year: +18.0%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 1989 to 2025.
What are WST's profit margins?
West Pharmaceutical Services, Inc. net profit margin is +16.1%, operating margin is +20.1%, and gross margin is +35.9%. Above-average net margins reflect strong pricing power and competitive moat. Return on Equity is +16.9%.
Is WST growing earnings?
WST earnings growth is slowing. Current YoY EPS growth of +1.6% trails the 5-year CAGR of +8.3%. TTM net income is $565M.
What was WST's best earnings year?
West Pharmaceutical Services, Inc.'s highest annual net income on record is $662M, achieved in fiscal year 2021. Earnings history on this page spans 1989 to 2025 and includes all annual and quarterly figures.
What were WST's earnings last quarter?
WST's most recent reported quarter was Q2 2026. Net income was $154M with diluted EPS of $2.15. For a full breakdown of all quarters, see the quarterly earnings table on this page.